Drug Trial Radar · NCT07365319
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
750
Planned (sponsor's estimate)
Start
Jun 15, 2026
Primary completion
Dec 31, 2035
Study completion Dec 31, 2040
Sponsor
- Lead sponsor
- Eikon TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- Merck Sharp & Dohme LLC
- First posted
- Jan 26, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to evaluate the safety and efficacy of EIK1001 administered intravenously in combination with pembrolizumab and histologically appropriate chemotherapy for patients with stage 4 NSCLC.
Conditions
- Non Small Cell Lung Cancer (Squamous or Non Squamous)
- Stage 4 NSCLC
Interventions
EIK1001Drug
EIK1001 is a Toll like receptor 7/8 (TLR 7/8) dual agonist
Pembrolizumab (KEYTRUDA®)Drug
PD-1 inhibitor
PlaceboDrug
Placebo control
Paclitaxel + CarboplatinDrug
SOC Chemotherapy for squamous NSCLC
Nab-paclitaxel + CarboplatinDrug
SOC Chemotherapy for squamous NSCLC
Pemetrexed + Cisplatin /CarboplatinDrug
SOC Chemotherapy for non-squamous NSCLC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS)Time frame: Through study completion, up to 6 years
- Overall survival (OS)Time frame: Through study completion, up to 10 years
- Objective Response (OR)Time frame: Through study completion, up to 6 years
Locations
52 sites in 14 countries. Site status is shown where the registry gives one.
Southern Cancer Center, P.C.
Daphne, Alabama · Recruiting
Los Angeles Cancer Network
Glendale, California · Recruiting
Providence St. Joseph Hospital
Orange, California · Recruiting
Rocky Mountain Cancer Centers, LLP
Pueblo, Colorado · Recruiting
Omnicure Clinical Research
Doral, Florida · Recruiting
Florida Clinical Trials Group
Plantation, Florida · Recruiting
Florida Clinical Trials Group - Tamarac
Tamarac, Florida · Recruiting
OSF Saint Francis Medical Center
Peoria, Illinois · Recruiting
University of New Mexico - Comprehensive Cancer Center
Albuquerque, New Mexico · Recruiting
NYU Langone Hospital Long Island
Mineola, New York · Recruiting
NYU Langone Hospital Manhattan
New York, New York · Recruiting
Jacobi Medical Center - Albert Einstein College of Medicine
The Bronx, New York · Recruiting
White Plains Hospital
White Plains, New York · Recruiting
Tennessee Oncology
Nashville, Tennessee · Recruiting
The Center for Cancer and Blood Disorders
Fort Worth, Texas · Recruiting
Blue Ridge Cancer Center
Blacksburg, Virginia · Recruiting
Virginia Cancer Specialists, PC
Fairfax, Virginia · Recruiting
Shenandoah Oncology P.C.
Winchester, Virginia · Recruiting
Fundación de Estudios Clínicos
Rosario, Santa Fe Province, Argentina · Recruiting
Cancer Care Northern Beaches
Frenchs Forest, New South Wales, Australia · Recruiting
Calvary Mater Newcastle Hospital
Waratah, New South Wales, Australia · Recruiting
Peninsula and Southeast Oncology (PASO) Medical
Frankston, Victoria, Australia · Recruiting
Sunshine Hospital - Western Health
Saint Albans, Victoria, Australia · Recruiting
Kepler Universitaetsklinikum
Linz, Austria · Recruiting
Centre Hospitalier Universitaire Brugmann
Brussels, Belgium · Recruiting
Hospital Brasília Unidade Lago Sul
Brasília, Brazil · Recruiting
CRIO - Centro Regional Integrado de Oncologia
Fortaleza, Ceará, Brazil · Recruiting
Hospital Evangélico de Cachoeiro de Itapemirim
Cachoeiro de Itapemirim, Espírito Santo, Brazil · Recruiting
Nucleo de Oncologia da Bahia
Salvador, Estado de Bahia, Brazil · Recruiting
Oncoclinicas Rio de Janeiro
Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting
Clinica de Hematologia e Oncologia Viver Ltda
Santa Maria, Rio Grande do Sul, Brazil · Recruiting
Katholische Marienkrankenhaus gGmbH
Hamburg, Germany · Recruiting
University Hospital Carl Gustav Carus Dresden
Dresden, Saxony, Germany · Recruiting
Henry Dunant Hospital Center
Athens, Greece · Recruiting
4th Department of Medical Oncology, European Interbalkan Medical Center
Thessaloniki, Greece · Recruiting
Hospital Genesis
Thessaloniki, Central Macedonia, Greece · Recruiting
Policlinico Campus Bio-Medico
Roma, Italy · Recruiting
GCPMED Sp. z o.o., Centrum Medyczne iMed24
Krakow, Lesser Poland Voivodeship, Poland · Recruiting
Medisprof Cancer Center
Cluj-Napoca, Cluj, Romania · Recruiting
The Medical Oncology Centre of Rosebank
Saxonwold, Gauteng, South Africa · Recruiting
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.